Literature DB >> 10754311

Mass spectrometric characterization of a discontinuous epitope of the HIV envelope protein HIV-gp120 recognized by the human monoclonal antibody 1331A.

E O Hochleitner1, M K Gorny, S Zolla-Pazner, K B Tomer.   

Abstract

The characterization of a discontinuous epitope in the C5 region of the HIV envelope protein HIV-gp120, recognized by 1331A, a human mAb, is reported. Regions involved in affinity binding in the HIV-gp120 molecule were identified by epitope excision/extraction methods followed by matrix assisted laser desorption-time of flight mass spectrometry. In epitope excision, the protein is bound in its native conformation to an immobilized Ab and then digested with proteolytic enzymes. In epitope extraction, the protein is first digested and subsequently allowed to react with the Ab. A series of proteolytic digestions of the 1331A/HIV-gp120 complex allowed the identification of protected amino acids in two noncontinuous regions of the C5 region of HIV-gp120. Interaction of the Ab with amino acids I487 and E507 of HIV-gp120 is essential for efficient binding. This is the first application of this approach for the identification and characterization of a discontinuous epitope. The results are consistent with molecular modeling results, indicating that these amino acids are located on opposite sides of a hydrophobic pocket. This pocket is thought to be of importance for the interaction of HIV-gp120 with the transmembrane protein HIV-gp41.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10754311     DOI: 10.4049/jimmunol.164.8.4156

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Genetic and structural determinants of virus neutralizing antibodies.

Authors:  J E Crowe; R O Suara; S Brock; N Kallewaard; F House; J H Weitkamp
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  MALDI/MS-based epitope mapping of antigens bound to immobilized antibodies.

Authors:  Carol E Parker; Kenneth B Tomer
Journal:  Mol Biotechnol       Date:  2002-01       Impact factor: 2.695

3.  Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5.

Authors:  C E Parker; L J Deterding; C Hager-Braun; J M Binley; N Schülke; H Katinger; J P Moore; K B Tomer
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Rapid and sensitive identification of epitope-containing peptides by direct matrix-assisted laser desorption/ionization tandem mass spectrometry of peptides affinity-bound to antibody beads.

Authors:  Christina S Raska; Carol E Parker; Susan W Sunnarborg; R Marshall Pope; David C Lee; Gary L Glish; Christoph H Borchers
Journal:  J Am Soc Mass Spectrom       Date:  2003-10       Impact factor: 3.109

5.  In vivo alteration of humoral responses to HIV-1 envelope glycoprotein gp120 by antibodies to the CD4-binding site of gp120.

Authors:  Maria Luisa Visciano; Michael Tuen; Miroslaw K Gorny; Catarina E Hioe
Journal:  Virology       Date:  2007-12-04       Impact factor: 3.616

6.  The antigenic determinants on HIV p24 for CD4+ T cell inhibiting antibodies as determined by limited proteolysis, chemical modification, and mass spectrometry.

Authors:  Jason G Williams; Kenneth B Tomer; Catarina E Hioe; Susan Zolla-Pazner; Philip J Norris
Journal:  J Am Soc Mass Spectrom       Date:  2006-07-27       Impact factor: 3.109

Review 7.  Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design.

Authors:  Susan Zolla-Pazner; Timothy Cardozo
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

8.  Epitope mapping of human VWF A3 recognized by monoclonal antibody SZ-123 and SZ-125 using MALDI mass spectrometry.

Authors:  Miao Jiang; Yiming Zhao; Fei Shen; Fuqiang Wang; Yang He; Changgeng Ruan
Journal:  Int J Hematol       Date:  2011-08-06       Impact factor: 2.490

9.  Characterization of the Streptococcus mutans P1 epitope recognized by immunomodulatory monoclonal antibody 6-11A.

Authors:  Nikki R Rhodin; Jenny M Cutalo; Kenneth B Tomer; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Structural elucidation of critical residues involved in binding of human monoclonal antibodies to hepatitis C virus E2 envelope glycoprotein.

Authors:  Roxana E Iacob; Zhenyong Keck; Oakley Olson; Steven K H Foung; Kenneth B Tomer
Journal:  Biochim Biophys Acta       Date:  2008-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.